Syllabus M Pharm
Syllabus M Pharm
Syllabus M Pharm
Objectives
Upon completion of this course it is expected that students shall be able to :
Understand the elements of pharmaceutical care and provide
comprehensive patient care services
Interpret the laboratory results to aid the clinical diagnosis of various
disorders
Provide integrated, critically analyzed medicine and poison information
to enable healthcare professionals in the efficient patient management
THEORY 60 Hrs
1. Introduction to Clinical Pharmacy: Definition, evolution and 12
scope of clinical pharmacy, International and national scenario of Hrs
clinical pharmacy practice, Pharmaceutical care
Clinical Pharmacy Services: Ward round participation, Drug
therapy review (Drug therapy monitoring including medication
order review, chart endorsement, clinical review and pharmacist
interventions)
188
Lab Data Interpretation: Hematological tests, Renal function
tests, Liver function tests
REFERENCES
1. A Textbook of Clinical Pharmacy Practice – Essential concepts and skills –
Parthasarathi G, Karin Nyfort-Hansen and Milap Nahata
2. Practice Standards and Definitions - The Society of Hospital Pharmacists
of Australia
3. Basic skills in interpreting laboratory data - Scott LT, American Society of
Health System Pharmacists Inc
4. Relevant review articles from recent medical and pharmaceutical literature.
189
PHARMACOTHERAPEUTICS-I
(MPP 102T)
Scope
This course aims to enable the students to understand the different treatment
approaches in managing various disease conditions. Also, it imparts knowledge
and skills in optimizing drug therapy of a patient by individualizing the treatment
plan through evidence-based medicines.
Objectives
Upon completion of this course it is expected that students shall be able to:
Describe and explain the rationale for drug therapy
Summarize the therapeutic approach for management of various
disease conditions including reference to the latest available evidence
Discuss the clinical controversies in drug therapy and evidence based
medicine
Prepare individualized therapeutic plans based on diagnosis
Identify the patient specific parameters relevant in initiating drug
therapy, and monitoring therapy (including alternatives, time- course of
clinical and laboratory indices of therapeutic response and adverse
effect/s)
THEORY 60 Hrs
Etiopathogenesis and pharmacotherapy of diseases
associated with following systems
190
5 Bone and joint disorders: Rheumatoid arthritis, Osteoarthritis, 12
Gout, Osteoporosis Hrs
REFERENCES
1. Roger and Walker. Clinical Pharmacy and Therapeutics - Churchill
Livingstone publication
2. Joseph T. Dipiro et al. Pharmacotherapy: A Pathophysiologic Approach-
Appleton & Lange
3. Robins SL. Pathologic basis of disease -W.B. Saunders publication
4. Eric T. Herfindal. Clinical Pharmacy and Therapeutics- Williams and
Wilkins Publication
5. Lloyd Young and Koda-Kimble MA Applied Therapeutics: The clinical Use
of Drugs- Lippincott Williams and Wilkins
6. Chisholm- Burns Wells Schwinghammer Malone and Joseph P Dipiro.
Pharmacotherapy Principles and practice-– McGraw Hill Publication
7. Carol Mattson Porth. Principles of Pathophysiology- Lippincott Williams
and Wilkins
8. Harrison's. Principles of Internal Medicine - McGraw Hill
9. Relevant review articles from recent medical and pharmaceutical literature
191
HOSPITAL & COMMUNITY PHARMACY
(MPP 103T)
Scope
This course is designed to impart basic knowledge and skills that are required to
practice pharmacy in both hospital and community settings.
Objectives
Upon completion of this course it is expected that students shall be able to:
Understand the organizational structure of hospital pharmacy
Understand drug policy and drug committees
Know about procurement & drug distribution practices
Know the admixtures of radiopharmaceuticals
Understand the community pharmacy management
Know about value added services in community pharmacies
THEORY 60 Hrs
1. Introduction to Hospitals – Definition, classification, 12
organizational structure Hrs
Hospital Pharmacy: Definition, Relationship of hospital
pharmacy department with other departments, Organizational
structure, legal requirements, work load statistics, Infrastructural
requirements, Hospital Pharmacy Budget and Hospital Pharmacy
management
Hospital Drug Policy: Pharmacy & Therapeutics Committee,
Infection Control committee, Research & Ethics Committee,
Management of Medicines as per NABH
192
Community Pharmacy management: Legal requirements to
start community pharmacy, site selection, lay out & design, drug
display, super drug store model, accounts and audits, Good
dispensing practices, Different softwares & databases used in
community pharmacies. Entrepreneurship in community
pharmacy.
REFERENCES
1. Hospital Pharmacy - Hassan WE. Lea and Febiger publication.
2. Textbook of hospital pharmacy - Allwood MC and Blackwell.
3. Avery’s Drug Treatment, Adis International Limited.
4. Community Pharmacy Practice – Ramesh Adepu, BSP Publishers,
Hyderabad
5. Remington Pharmaceutical Sciences.
6. Relevant review articles from recent medical and pharmaceutical literature
193
CLINICAL RESEARCH
(MPP 104T)
Scope
This course aims to provide the students an opportunity to learn drug
development process especially the phases of clinical trials and also the ethical
issues involved in the conduct of clinical research. Also, it aims to imparts
knowledge and develop skills on conceptualizing, designing, conducting and
managing clinical trials.
Objectives
Upon completion of this course it is expected that students shall be able to:
Know the new drug development process.
Understand the regulatory and ethical requirements.
Appreciate and conduct the clinical trials activities
Know safety monitoring and reporting in clinical trials
Manage the trial coordination process
THEORY 60 Hrs
1. Drug development process: Introduction, various approaches to 12
drug discovery, Investigational new drug application submission Hrs
Ethics in Biomedical Research: Ethical Issues in Biomedical
Research – Principles of ethics in biomedical research, Ethical
committee [institutional review board] - its constitution and
functions, Challenges in implementation of ethical guidelines, ICH
GCP guidelines and ICMR guidelines in conduct of Clinical trials,
Drug Safety Reporting.
194
3 Clinical trial Documents: Guidelines to the preparation of 12
following documents: Protocols, Investigator’s Brochure, Informed Hrs
Consent Form, Case report forms, Contracts and agreements,
Dairy Cards
Clinical Trial Start up activities: Site Feasibility Studies,
Site/Investigator selection, Pre-study visit, Investigator meeting,
Clinical trial agreement execution, Ethics committee document
preparation and submission
195
REFERENCES
1. Principles and practice of pharmaceutical medicine, Second edition.
Authors:Lionel. D. Edward, Aadrew.J.Flether Anthony W Fos , Peter D
Sloaier Publisher:Wiley;
2. Handbook of clinical research. Julia Lloyd and Ann Raven Ed. Churchill
Livingstone
3. Principles of Clinical Research edited by Giovanna di Ignazio, Di Giovanna
and Haynes.
4. Central Drugs Standard Control Organization. Good Clinical Practices-
Guidelines for Clinical Trials on Pharmaceutical Products in India. New
Delhi: Ministry of Health.
5. International Conference on Harmonisation of Technical requirements for
registration of Pharmaceuticals for human use. ICH Harmonised Tripartite
Guideline. Guideline for Good Clinical Practice.E6; May 1996.
6. Ethical Guidelines for Biomedical Research on Human Subjects. Indian
Council of Medical Research, New Delhi.
7. Textbook of Clinical Trials edited by David Machin, Simon Day and Sylvan
Green, John Wiley and Sons.
8. Clinical Data Management edited by R K Rondels, S A Varley, C F Webbs.
Second Edition, Jan 2000, Wiley Publications.
9. Goodman & Gilman: JG Hardman, LE Limbard, McGraw Hill Publications.
10. Relevant review articles from recent medical and pharmaceutical literature.
196
PHARMACY PRACTICE PRACTICAL – I
(MPP 105P)
197